242 related articles for article (PubMed ID: 19955413)
1. Human cancers converge at the HIF-2alpha oncogenic axis.
Franovic A; Holterman CE; Payette J; Lee S
Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21306-11. PubMed ID: 19955413
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
3. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
4. Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.
Day TF; Kallakury BVS; Ross JS; Voronel O; Vaidya S; Sheehan CE; Kasid UN
Mol Cancer Res; 2019 May; 17(5):1207-1219. PubMed ID: 30647104
[TBL] [Abstract][Full Text] [Related]
5. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible factor 2α/insulin-like growth factor receptor signal loop supports the proliferation and Oct-4 maintenance of mouse germline stem cells.
Huang YH; Lin MH; Wang PC; Wu YC; Chiang HL; Wang YL; Chang JH; Huang YK; Gu SY; Ho HN; Ling TY
Mol Hum Reprod; 2014 Jun; 20(6):526-37. PubMed ID: 24598112
[TBL] [Abstract][Full Text] [Related]
7. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH
Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022
[TBL] [Abstract][Full Text] [Related]
8. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
9. HIF-2alpha deletion promotes Kras-driven lung tumor development.
Mazumdar J; Hickey MM; Pant DK; Durham AC; Sweet-Cordero A; Vachani A; Jacks T; Chodosh LA; Kissil JL; Simon MC; Keith B
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14182-7. PubMed ID: 20660313
[TBL] [Abstract][Full Text] [Related]
10. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
[TBL] [Abstract][Full Text] [Related]
11. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling.
Sun X; Xu Y; Wang Y; Chen Q; Liu L; Bao Y
Med Sci Monit; 2018 May; 24():3193-3203. PubMed ID: 29763936
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
Wan J; Wu W
J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
[TBL] [Abstract][Full Text] [Related]
14. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.
Mahajan S; Dammai V; Hsu T; Kraft AS
Carcinogenesis; 2008 Sep; 29(9):1734-41. PubMed ID: 18544564
[TBL] [Abstract][Full Text] [Related]
16. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
[TBL] [Abstract][Full Text] [Related]
17. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.
Smith K; Gunaratnam L; Morley M; Franovic A; Mekhail K; Lee S
Cancer Res; 2005 Jun; 65(12):5221-30. PubMed ID: 15958567
[TBL] [Abstract][Full Text] [Related]
18. HIF-2α Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells.
Nauta TD; Duyndam MC; Weijers EM; van Hinsbergh VM; Koolwijk P
PLoS One; 2016; 11(8):e0160700. PubMed ID: 27490118
[TBL] [Abstract][Full Text] [Related]
19. The p75 neurotrophin receptor enhances HIF-dependent signaling in glioma.
Tong B; Pantazopoulou V; Johansson E; Pietras A
Exp Cell Res; 2018 Oct; 371(1):122-129. PubMed ID: 30092219
[TBL] [Abstract][Full Text] [Related]
20. HIF-2alpha: many cancers, one engine?
Franovic A; Lee S
Cell Cycle; 2010 Mar; 9(5):859-60. PubMed ID: 20348840
[No Abstract] [Full Text] [Related]
[Next] [New Search]